1Dorne, JL, Walton, K & Renwick, AG (2001) Human variability in glucuronidation in relation to uncertainty factors for risk assessment. Food Chem Toxicol 39, 1153–1173.
2Silberberg, M, Morand, C, Manach, C, Scalbert, A & Remesy, C (2005) Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism. Life Sci 77, 3156–3167.
3Terao, J (1999) Dietary flavonoids as antioxidants in vivo: conjugated metabolites of ( − )-epicatechin and quercetin participate in antioxidative defense in blood plasma. J Med Invest 46, 159–168.
4Lesser, S, Cermak, R & Wolffram, S (2004) Bioavailability of quercetin in pigs is influenced by the dietary fat content. J Nutr 134, 1508–1511.
5Visioli, F, Galli, C, Grande, S, Colonnelli, K, Patelli, C, Galli, G & Caruso, D (2003) Hydroxytyrosol excretion differs between rats and human and depends on the vehicle of administration. J Nutr 133, 2612–2615.
6Azuma, K, Ippoushi, K, Ito, H, Higashio, H & Terao, J (2002) Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. J Agric Food Chem 50, 1706–1712.
7Yamashita, S, Sakane, T, Harada, M, Sugiura, N, Koda, H, Kiso, Y & Sezaki, H (2002) Absorption and metabolism of antioxidative polyphenolic compounds in red wine. Ann N Y Acad Sci 957, 325–328.
8Serafini, M, Ghiselli, A & Ferro-Luzzi, A (1996) In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 50, 28–32.
9Serafini, M, Bugianesi, R, Maiani, G, Valtuena, S, De Santis, S & Crozier, A (2003) Plasma antioxidants from chocolate. Nature 424, 1013.
10Goldberg, DM, Yan, J & Soleas, G (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36, 79–87.
11Manach, C, Scalbert, A, Morand, C, Rémésy, C & Jiménez, L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727–747.
12Manach, C & Donovan, JL (2004) Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 38, 771–785.
13Zamek-Gliszczynski, MJ, Hoffmaster, KA, Nezasa, K, Tallman, MN & Brouwer, LR (2006) Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci 27, 447–486.
14Chan, W, Cui, L, Xu, G & Cai, Z (2006) Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 20, 1755–1760.
15Miners, JO & Mackenzie, PI (1991) Drug glucuronidation in humans. Pharmac Ther 51, 347–369.
16Spencer, JP, Chowrimootoo, G, Choudhury, R, Debnam, ES, Srai, SK & Rice-Evans, C (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458, 224–230.
17Critchley, JA, Critchley, LAH, Anderson, PJ & Tomlinson, B (2005) Differences in the single oral dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects. J Clin Pharm Ther 30, 179–184.
18Roura, E, Andres-Lacueva, C, Estruch, R, Mata-Bilbao, L, Waterhause, AL & Lamuela-Raventos, RM (2007) Milk does not affect the bioavailability of cocoa powder flavonoid in healthy humans. Ann Nutr Metab 51, 493–498.
19Roura, E, Andres-Lacueva, C, Jauregui, O, Badia, E, Estruch, R, Izquierdo-Pulido, M & Lamuela-Raventos, RM (2005) Rapid liquid chromatography tandem mass spectrometry assay to quantify plasma ( − )-epicatechin metabolites after ingestion of a standard portion of cocoa beverage in humans. J Agric Food Chem 53, 6190–6194.
20Roura, E, Andres-Lacueva, C, Estruch, R & Lamuela-Raventos, RM (2006) Total polyphenol intake estimated by a modified Folin–Ciocalteu assay of urine. Clin Chem 52, 749–752.
21Donovan, JL, Kasim-Karakas, S, German, JB & Waterhouse, AL (2002) Urinary excretion of catechin metabolites by human subjects after red wine consumption. Br J Nutr 87, 31–37.
22Arts, MJ, Haenen, GR, Wilms, LC, Beetstra, SA, Heijnen, CG, Voss, HP & Bast, AJ (2002) Interactions between flavonoids and proteins: effect on the total antioxidant capacity. J Agric Food Chem 50, 1184–1187.
23Schroeter, H, Holt, RR, Orozco, TJ, Schmitz, HH & Keen, CL (2003) Nutrition: milk and absorption of dietary flavanols. Nature 426, 787–788.
24Yamamoto, N, Moon, JH, Tsushida, T, Nagao, A & Terao, J (1999) Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch Biochem Biophys 372, 347–354.
25Natsume, M, Osakabe, N, Yasuda, A, Baba, S, Tokunaga, T, Kondo, K, Osawa, T & Terao, J (2004) In vitro antioxidative activity of ( − )-epicatechin glucuronide metabolites present in human and rat plasma. Free Rad Res 38, 1341–1348.
26Mullen, W, Edwards, CA & Crozier, A (2006) Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulfo-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96, 107–116.
27O'Leary, KA, Day, AJ, Needs, PW, Mellon, FA, O'Brien, NM & Williamson, G (2003) Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 65, 479–491.